Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q2 2026 (June 30)1holders −2
0new positions
2sold out
$1.63avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holder was Bank of New York Mellon Corp ($325K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $4.1M |
All 13F filers, Q1 2026 → Q2 2026: 2,808,000 shares sold, net −2,808,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $325K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.